Multicenter, Randomized, Double-blind, Parallel-group Study of Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease.

Trial Profile

Multicenter, Randomized, Double-blind, Parallel-group Study of Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 04 Sep 2013

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Crohn's disease
  • Focus Registrational; Therapeutic Use
  • Acronyms Crodex
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Sep 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 10 Mar 2012 This trial has been discontinued in Italy and recruiting in Spain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top